MedKoo Cat#: 525953 | Name: Rauwolscine hydrochloride
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Rauwolscine hydrochloride, also known as yohimbine hydrochloride, is an alpha2-Adrenergic antagonist and partial agonist at 5-HT1A receptors.

Chemical Structure

Rauwolscine hydrochloride
Rauwolscine hydrochloride
CAS#6211-32-1 (HCl)

Theoretical Analysis

MedKoo Cat#: 525953

Name: Rauwolscine hydrochloride

CAS#: 6211-32-1 (HCl)

Chemical Formula: C21H27ClN2O3

Exact Mass:

Molecular Weight: 390.91

Elemental Analysis: C, 64.52; H, 6.96; Cl, 9.07; N, 7.17; O, 12.28

Price and Availability

Size Price Availability Quantity
50mg USD 250.00 2 Weeks
100mg USD 400.00 2 Weeks
250mg USD 750.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
131-03-3 (free base) 6211-32-1 (HCl) 28834-05-1 (phosphate)
Synonym
Rauwolscine hydrochloride; NSC 407307; alpha-Yohimbine; Corynanthidine, Isoyohimbine; Mesoyohimbine, yohimbine hydrochloride
IUPAC/Chemical Name
Methyl (1S,15S,18S,19S,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate hydrochlori
InChi Key
PIPZGJSEDRMUAW-ZKKXXTDSSA-N
InChi Code
InChI=1S/C21H26N2O3.ClH/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24;/h2-5,12,15,17-19,22,24H,6-11H2,1H3;1H/t12-,15+,17+,18+,19+;/m1./s1
SMILES Code
O[C@@H](CC1)[C@@H](C(OC)=O)[C@@H]2[C@H]1CN3CCC4=C(NC5=CC=CC=C54)[C@@H]3C2.Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
Rauwolscine is a selective and reversible α2-adrenergic receptor antagonist (Ki = 12 nM).1 Rauwolscine also acts as a receptor antagonist at the serotonin 5-HT2B receptor (Ki = 14.3 nM) and as a weak partial agonist at 5-HT1A (IC50 = 1.3 µM). α2-adrenergic receptor antagonists like rauwolscine have numerous applications, including the modulation of mood and behavior.
In vitro activity:
When using [3H]rauwolscine as the radioligand, competition curves for antagonist structures modeled to a single binding site, while agonist competition typically resulted in curves that best fit a two site binding model. Many of the compounds with antagonist structures displayed higher affinity for the 5-HT2B receptor when [3H]rauwolscine was the radioligand. Reference: Naunyn Schmiedebergs Arch Pharmacol. 1998 Jan;357(1):17-24. https://pubmed.ncbi.nlm.nih.gov/9459568/
In vivo activity:
In this study, more severe emotion-related impulsivity was related to more impulsive decisions in the rauwolscine but not in the placebo group. Results provide some of the first experimental evidence that emotion-related impulsivity is related to differential behavioural responses in the face of high arousal. Reference: Pharmacol Biochem Behav. 2023 Apr;225:173557. https://pubmed.ncbi.nlm.nih.gov/37127224/
Solvent mg/mL mM
Solubility
DMF 0.1 0.26
DMSO 2.0 5.12
Water 10.0 25.58
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 390.91 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
1. Wainscott DB, Sasso DA, Kursar JD, Baez M, Lucaites VL, Nelson DL. [3H]Rauwolscine: an antagonist radioligand for the cloned human 5-hydroxytryptamine2b (5-HT2B) receptor. Naunyn Schmiedebergs Arch Pharmacol. 1998 Jan;357(1):17-24. doi: 10.1007/pl00005133. PMID: 9459568. 2. Shen SG, Zhang D, Hu HT, Li JH, Wang Z, Ma QY. Effects of alpha-adrenoreceptor antagonists on apoptosis and proliferation of pancreatic cancer cells in vitro. World J Gastroenterol. 2008 Apr 21;14(15):2358-63. doi: 10.3748/wjg.14.2358. PMID: 18416462; PMCID: PMC2705090. 3. Herman AM, Elliott MV, Johnson SL. Emotion-related impulsivity moderates the role of arousal on reflection impulsivity. Pharmacol Biochem Behav. 2023 Apr;225:173557. doi: 10.1016/j.pbb.2023.173557. Epub 2023 Apr 29. PMID: 37127224. 4. Fu T, Qin X, Ma Y, Yuan X, Wu S, Ye X, Dang Y. Yohimbine hydrochloride inhibits skin melanin synthesis by regulating wnt/β-catenin and p38/MAPK signal pathways. J Dermatol Sci. 2022 Jul;107(1):17-23. doi: 10.1016/j.jdermsci.2022.06.005. Epub 2022 Jul 4. PMID: 35840473.
In vitro protocol:
1. Wainscott DB, Sasso DA, Kursar JD, Baez M, Lucaites VL, Nelson DL. [3H]Rauwolscine: an antagonist radioligand for the cloned human 5-hydroxytryptamine2b (5-HT2B) receptor. Naunyn Schmiedebergs Arch Pharmacol. 1998 Jan;357(1):17-24. doi: 10.1007/pl00005133. PMID: 9459568. 2. Shen SG, Zhang D, Hu HT, Li JH, Wang Z, Ma QY. Effects of alpha-adrenoreceptor antagonists on apoptosis and proliferation of pancreatic cancer cells in vitro. World J Gastroenterol. 2008 Apr 21;14(15):2358-63. doi: 10.3748/wjg.14.2358. PMID: 18416462; PMCID: PMC2705090.
In vivo protocol:
1. Herman AM, Elliott MV, Johnson SL. Emotion-related impulsivity moderates the role of arousal on reflection impulsivity. Pharmacol Biochem Behav. 2023 Apr;225:173557. doi: 10.1016/j.pbb.2023.173557. Epub 2023 Apr 29. PMID: 37127224. 2. Fu T, Qin X, Ma Y, Yuan X, Wu S, Ye X, Dang Y. Yohimbine hydrochloride inhibits skin melanin synthesis by regulating wnt/β-catenin and p38/MAPK signal pathways. J Dermatol Sci. 2022 Jul;107(1):17-23. doi: 10.1016/j.jdermsci.2022.06.005. Epub 2022 Jul 4. PMID: 35840473.
1: Raczak-Gutknecht J, Frąckowiak T, Nasal A, Kornicka A, Sączewski F, Kaliszan R. Are Alpha-2D Adrenoceptor Subtypes Involved in Rat Mydriasis Evoked by New Imidazoline Derivatives: Marsanidine and 7-Methylmarsanidine? Dose Response. 2017 Apr 18;15(2):1559325817701213. doi: 10.1177/1559325817701213. eCollection 2017 Apr-Jun. PubMed PMID: 28491012; PubMed Central PMCID: PMC5405787. 2: Del Sole MJ, Nejamkin P, Cavilla V, Schaiquevich P, Moreno L. Comparison of two sedation protocols for short electroretinography in cats. J Feline Med Surg. 2017 Apr 1:1098612X17703011. doi: 10.1177/1098612X17703011. [Epub ahead of print] PubMed PMID: 28379112. 3: Angus JA, Rajasekaran P, Wright CE. Novel technique to determine the pK(A) of clonidine at prejunctional α(2)-adrenoceptors in cardiac and vascular sympathetic transmission. Eur J Pharmacol. 2017 Apr 5;800:81-95. doi: 10.1016/j.ejphar.2017.02.030. Epub 2017 Feb 17. PubMed PMID: 28219708. 4: Cobos-Puc LE, Sánchez-López A, Centurión D. Pharmacological analysis of the cardiac sympatho-inhibitory actions of moxonidine and agmatine in pithed spontaneously hypertensive rats. Eur J Pharmacol. 2016 Nov 15;791:25-36. doi: 10.1016/j.ejphar.2016.08.017. Epub 2016 Aug 24. PubMed PMID: 27565220. 5: Ribeiro AR, do Nascimento Valença JD, da Silva Santos J, Boeing T, da Silva LM, de Andrade SF, Albuquerque-Júnior RL, Thomazzi SM. The effects of baicalein on gastric mucosal ulcerations in mice: Protective pathways and anti-secretory mechanisms. Chem Biol Interact. 2016 Dec 25;260:33-41. doi: 10.1016/j.cbi.2016.10.016. Epub 2016 Oct 22. PubMed PMID: 27780710. 6: Ok SH, Kwon SC, Baik J, Hong JM, Oh J, Han JY, Sohn JT. Dexmedetomidine-Induced Contraction Involves CPI-17 Phosphorylation in Isolated Rat Aortas. Int J Mol Sci. 2016 Sep 30;17(10). pii: E1663. PubMed PMID: 27706026; PubMed Central PMCID: PMC5085696. 7: Kundashev UK, Salenko YA, Morozov IS, Zurdinov AZ, Barchukov VG. [EFFECT OF MEDIATOR-TYPE DRUGS ON HUMAN PSYCHOPHYSIOLOGICAL STATUS DURING MODEL OPERATOR ACTIVITY]. Eksp Klin Farmakol. 2016;79(2):9-13. Russian. PubMed PMID: 27416676. 8: Shen J, Li L, Jiang L, Fu G. [Effect of dexmedetomidine hydrochloride on H2O2-induced oxidative stress and inflammatory response in Kupffer cells]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2016 May;41(5):477-81. doi: 10.11817/j.issn.1672-7347.2016.05.005. Chinese. PubMed PMID: 27269921. 9: Neha, Ansari MM, Khan HA. Yohimbine hydrochloride ameliorates collagen type-II-induced arthritis targeting oxidative stress and inflammatory cytokines in Wistar rats. Environ Toxicol. 2017 Feb;32(2):619-629. doi: 10.1002/tox.22264. Epub 2016 Mar 29. PubMed PMID: 27028940. 10: Ozerov AA, Bagmetova VV, Chernysheva YV, Tyurenkov IN. Comparison of the Efficiency of Adeprophen and Antidepressants of Various Groups on the Model of Reserpine-Induced Depression in Rats. Bull Exp Biol Med. 2016 Mar;160(5):649-52. doi: 10.1007/s10517-016-3240-6. Epub 2016 Mar 29. PubMed PMID: 27021092. 11: Tamano R, Ishida M, Asaki T, Hasegawa M, Shinohara S. Effect of spinal monoaminergic neuronal system dysfunction on pain threshold in rats, and the analgesic effect of serotonin and norepinephrine reuptake inhibitors. Neurosci Lett. 2016 Feb 26;615:78-82. doi: 10.1016/j.neulet.2016.01.025. Epub 2016 Jan 19. PubMed PMID: 26806036. 12: Prus AJ, Mooney-Leber SM, Berquist MD 2nd, Pehrson AL, Porter NP, Porter JH. The antidepressant drugs fluoxetine and duloxetine produce anxiolytic-like effects in a schedule-induced polydipsia paradigm in rats: enhancement of fluoxetine's effects by the α2 adrenoceptor antagonist yohimbine. Behav Pharmacol. 2015 Aug;26(5):489-94. doi: 10.1097/FBP.0000000000000159. PubMed PMID: 26154437. 13: de Souza Rossignoli P, Yamamoto FZ, Pereira OC, Chies AB. Norepinephrine responses in rat renal and femoral veins are reinforced by vasoconstrictor prostanoids. Vascul Pharmacol. 2015 Sep;72:93-100. doi: 10.1016/j.vph.2015.06.017. Epub 2015 Jul 2. PubMed PMID: 26141930. 14: Bannister K, Patel R, Goncalves L, Townson L, Dickenson AH. Diffuse noxious inhibitory controls and nerve injury: restoring an imbalance between descending monoamine inhibitions and facilitations. Pain. 2015 Sep;156(9):1803-11. doi: 10.1097/j.pain.0000000000000240. PubMed PMID: 26010460. 15: Balogun SO, Damazo AS, de Oliveira Martins DT. Helicteres sacarolha A. St.- Hil. et al.: gastroprotective and possible mechanism of actions in experimental animals. J Ethnopharmacol. 2015 May 26;166:176-84. doi: 10.1016/j.jep.2015.03.021. Epub 2015 Mar 16. PubMed PMID: 25792014. 16: Jordan J, Shibao C, Biaggioni I. Multiple system atrophy: using clinical pharmacology to reveal pathophysiology. Clin Auton Res. 2015 Feb;25(1):53-9. doi: 10.1007/s10286-015-0271-4. Epub 2015 Mar 11. PubMed PMID: 25757803; PubMed Central PMCID: PMC4431657. 17: Murai N, Fushiki H, Honda S, Murakami Y, Iwashita A, Irie M, Tamura S, Nagakura Y, Aoki T. Relationship between serotonin transporter occupancies and analgesic effects of AS1069562, the (+)-isomer of indeloxazine, and duloxetine in reserpine-induced myalgia rats. Neuroscience. 2015 Mar 19;289:262-9. doi: 10.1016/j.neuroscience.2014.12.065. Epub 2015 Jan 13. PubMed PMID: 25595980. 18: Di Miceli M, Gronier B. Psychostimulants and atomoxetine alter the electrophysiological activity of prefrontal cortex neurons, interaction with catecholamine and glutamate NMDA receptors. Psychopharmacology (Berl). 2015 Jun;232(12):2191-205. doi: 10.1007/s00213-014-3849-y. Epub 2015 Jan 10. PubMed PMID: 25572531. 19: Cegielska-Perun K, Tatarkiewicz J, Siwek A, Dybała M, Bujalska-Zadrożny M. Mechanisms of morphine-venlafaxine interactions in diabetic neuropathic pain model. Pharmacol Rep. 2015 Feb;67(1):90-6. doi: 10.1016/j.pharep.2014.08.008. Epub 2014 Aug 21. PubMed PMID: 25560581. 20: Karabowicz P, Schlicker E, Pędzińska-Betiuk A, Kloza M, Malinowska B. The adrenal medulla, not CB1 receptors, mediates the inhibitory effect of acute transverse aortic constriction on the neurogenic vasopressor response. Life Sci. 2015 Oct 1;138:86-93. doi: 10.1016/j.lfs.2014.11.032. Epub 2014 Dec 11. PubMed PMID: 25498898.